Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Welldorm 707mg tablets
0401010C0BBAAAA
|
Welldorm (tab) | Cloral betaine | Central Nervous System | No data available |
|
Winfex XL 150mg capsules
0403040W0BEABAE
|
Winfex | Venlafaxine | Central Nervous System | No data available |
|
Winfex XL 75mg capsules
0403040W0BEAAAD
|
Winfex | Venlafaxine | Central Nervous System | No data available |
|
Xanax 250microgram tablets
0401020A0BBAAAA
|
Xanax | Alprazolam | Central Nervous System | No data available |
|
Xanax 500microgram tablets
0401020A0BBABAB
|
Xanax | Alprazolam | Central Nervous System | No data available |
|
Xeplion 150mg/1.5ml and 100mg/1ml treatment initiation pack
0402020ABBBAEAE
|
Xeplion | Paliperidone | Central Nervous System | No data available |
|
Xyquila 10mg powder for solution for injection vials
040201060BEAAAN
|
Xyquila | Olanzapine | Central Nervous System | No data available |
|
Yeast-Vite tablets
0404000D0BGAAA0
|
Yeast-Vite | Caffeine | Central Nervous System | No data available |
|
Zalasta 15mg orodispersible tablets
040201060BCAIAU
|
Zalasta | Olanzapine | Central Nervous System | No data available |
|
Zalasta 15mg tablets
040201060BCAEAL
|
Zalasta | Olanzapine | Central Nervous System | No data available |
|
Zalasta 2.5mg tablets
040201060BCAAAD
|
Zalasta | Olanzapine | Central Nervous System | No data available |
|
Zalasta 20mg orodispersible tablets
040201060BCAJAV
|
Zalasta | Olanzapine | Central Nervous System | No data available |
|
Zalasta 20mg tablets
040201060BCAFAQ
|
Zalasta | Olanzapine | Central Nervous System | No data available |
|
Zalasta 5mg orodispersible tablets
040201060BCAGAS
|
Zalasta | Olanzapine | Central Nervous System | No data available |
|
Zalasta 7.5mg tablets
040201060BCACAB
|
Zalasta | Olanzapine | Central Nervous System | No data available |
|
Zaleplon 10mg capsules
0401010W0AAABAB
|
Zaleplon | Zaleplon | Central Nervous System | No data available |
|
Zaleplon 5mg capsules
0401010W0AAAAAA
|
Zaleplon | Zaleplon | Central Nervous System | No data available |
|
Zalzo 10mg orodispersible tablets
0401010Y0BCABAE
|
Zalzo | Zolpidem tartrate | Central Nervous System | No data available |
|
Zalzo 5mg orodispersible tablets
0401010Y0BCAAAD
|
Zalzo | Zolpidem tartrate | Central Nervous System | No data available |
|
Zamadol 100mg/2ml solution for injection ampoules
040702040BDAFAB
|
Zamadol | Tramadol hydrochloride | Central Nervous System | No data available |
|
Zaponex 100mg orodispersible tablets
0402010C0BDAFAK
|
Zaponex | Clozapine | Central Nervous System | No data available |
|
Zaponex 200mg orodispersible tablets
0402010C0BDAGAL
|
Zaponex | Clozapine | Central Nervous System | No data available |
|
Zaponex 25mg orodispersible tablets
0402010C0BDADAI
|
Zaponex | Clozapine | Central Nervous System | No data available |
|
Zarontin 250mg capsules
0408010I0BCAAAA
|
Zarontin | Ethosuximide | Central Nervous System | No data available |
|
Zarontin 250mg/5ml syrup
0408010I0BCABAB
|
Zarontin | Ethosuximide | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.